SS
OMGA

SBI Securities’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

SBI Securities’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-415
Closed -$309 – 4245
2024
Q4 		$309 Buy
+415
New +$413 ﹤0.01% 3072

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

SBI Securities's OMGA Position: Q1 2025 in Review

SBI Securities sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 415 shares — an estimated $309 sold.

SBI Securities first reported a position in OMGA in Q4 2024 and held it in 1 quarter. The position peaked at $309 in Q4 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • SBI Securities reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • SBI Securities sold 415 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $309.
  • SBI Securities first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • SBI Securities's Omega Therapeutics, Inc. Common Stock position peaked at $309 in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on SBI Securities's 13F filing for Q1 2025, filed 2 May 2025.